What National Institutes of Health Stroke Scale (NIHSS) score ranges define mild, moderate, and severe stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NIHSS Score Ranges for Stroke Severity Classification

The NIHSS score ranges that define stroke severity are: mild stroke 0-5, moderate stroke 6-14, and severe stroke ≥15.

Standardized Classification

The most recent and authoritative guideline consensus establishes clear NIHSS thresholds for categorizing acute stroke severity 1:

  • Mild stroke: NIHSS 0-5
  • Moderate stroke: NIHSS 6-14
  • Severe stroke: NIHSS ≥15

This classification system appears in the 2021 Valve Academic Research Consortium 3 (VARC-3) guidelines, which harmonized definitions across cardiovascular and neurological research 1.

Alternative Classification Systems

Some sources use slightly different categorization schemes, though these are less commonly applied in contemporary practice:

  • One classification defines scores <5 as "small stroke" and >20 as "large stroke" 1
  • Research studies have occasionally used five-tier systems: ≤5 (minor), 6-10 (mild), 11-15 (moderate), 16-20 (severe), >20 (very severe) 2

Prognostic Implications

The NIHSS score is the strongest predictor of stroke outcomes and directly influences treatment decisions 1:

  • NIHSS <10: Approximately 60-70% of patients achieve favorable outcomes at 1 year 1
  • NIHSS >20: Only 4-16% achieve favorable outcomes at 1 year 1
  • NIHSS >16: Forecasts high probability of death or severe disability 1
  • NIHSS <6: Forecasts good recovery 1

Clinical Application Considerations

The NIHSS should be assessed at presentation/admission within the first 24 hours 1. The scale ranges from 0 to 42 points across 15 items evaluating consciousness, vision, motor function, sensation, language, and attention 1.

Important caveat: Patients with NIHSS ≥20 have a 17% risk of intracranial hemorrhage with thrombolytic therapy, which must be weighed against potential benefits 1. Time-to-treatment windows may also vary by severity—moderate strokes (NIHSS 6-14) show benefit from treatment within 120 minutes, while time-to-treatment appears less predictive for mild and severe strokes 3.

All healthcare professionals involved in stroke care should be trained and certified in NIHSS administration to ensure reliable severity assessment and appropriate treatment decisions 1.

Related Questions

Is peri‑oral numbness a sign of stroke?
Can an intracerebral hemorrhage cause acute hypertension?
What is the recommended acute treatment protocol for a patient presenting with an acute stroke?
Are there articles that describe the clinical presentation of intracerebral hemorrhage versus ischemic infarction?
What is the recommended blood pressure management strategy for patients with stroke, including acute and long‑term control?
A patient with leprosy who developed a type 2 reaction (erythema nodosum leprosum) was treated with prednisone 40 mg daily for 2 weeks, then tapered by 5 mg every 2 weeks; when the dose reached 10 mg the tender skin lesions recurred. How long should prednisone be continued, and what is the overall management plan?
What is the recommended treatment for esophageal varices?
What is the recommended evaluation and management approach for abnormalities at the right ventricle–pulmonary artery (RV‑PA) junction?
In a 10‑year‑old pre‑pubertal girl presenting with acute severe genital bleeding, pallor, tachycardia, and hypotension, what cellular mechanisms of hemostasis may be altered and how do these alterations contribute to hypovolemic shock?
What is the recommended evaluation and treatment for a patient with acute scrotal pain suspected to be torsion of the testicular appendix?
For an 18‑year‑old woman who has just finished a two‑week course of intravaginal miconazole, what non‑oral long‑term maintenance treatment is recommended since 500 mg clotrimazole vaginal suppositories are unavailable in the United States?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.